Related Experiment Video
Updated: Aug 18, 2026

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
Published on: April 26, 2016
Liposomal formulations of a novel antitumor agent: drug loading and optimization
1Department of Pharmaceutical Development, Agouron Pharmaceuticals, Incorporated, San Diego, CA 92121, USA.
Abstract:
A lyophilized, parenteral, liposomal dosage form was developed for an insoluble novel antitumor agent. Drug loading optimization studies were conducted to achieve 100% drug loading while reaching drug concentrations up to 1.0%. The reconstituted, lyophilized product was similar in morphology, particle size, and drug concentration to the liquid product. Systemic delivery of the dosage form to mice resulted in drug plasma levels in the range considered necessary for antitumor activity.
Related Concept Videos
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability Enhancement: Drug Permeability Enhancement
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

